MSF drags Pfizer to court in India over patent on high-cost Gavi-funded vaccine
NewsNovember 24, 2017
The medical humanitarian aid organisation Médecins Sans Frontières has taken the Indian Patent Office to court over a patent it recently granted to Pfizer for the pneumonia vaccine, Prevenar 13. MSF argues that the patent will stifle competition, blocking the development of cheaper, generic versions of the vaccine.
The rest of the content is only available for subscribers.